Valproic Acid: A New Candidate of Therapeutic Application for the Acute Central Nervous System Injuries
- 31 January 2014
- journal article
- review article
- Published by Springer Nature in Neurochemical Research
- Vol. 39 (9) , 1621-1633
Abstract
Acute central nervous system (CNS) injuries, including stroke, traumatic brain injury (TBI), and spinal cord injury (SCI), are common causes of human disabilities and deaths, but the pathophysiology of these diseases is not fully elucidated and, thus, effective pharmacotherapies are still lacking. Valproic acid (VPA), an inhibitor of histone deacetylation, is mainly used to treat epilepsy and bipolar disorder with few complications. Recently, the neuroprotective effects of VPA have been demonstrated in several models of acute CNS injuries, such as stroke, TBI, and SCI. VPA protects the brain from injury progression via anti-inflammatory, anti-apoptotic, and neurotrophic effects. In this review, we focus on the emerging neuroprotective properties of VPA and explore the underlying mechanisms. In particular, we discuss several potential related factors in VPA research and present the opportunity to administer VPA as a novel neuropective agent.Keywords
This publication has 107 references indexed in Scilit:
- Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic strokeCell Death & Disease, 2013
- Advances in stroke therapyDrug Delivery and Translational Research, 2011
- Expression of Histone Deacetylases in Cellular Compartments of the Mouse Brain and the Effects of IschemiaTranslational Stroke Research, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- Valproic Acid Attenuates Blood–Brain Barrier Disruption in a Rat Model of Transient Focal Cerebral Ischemia: The Roles of HDAC and MMP-9 InhibitionJournal of Cerebral Blood Flow & Metabolism, 2010
- Inflammation After Stroke: Mechanisms and Therapeutic ApproachesTranslational Stroke Research, 2010
- Excessive HDAC activation is critical for neurodegeneration in the rd1 mouseCell Death & Disease, 2010
- Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2009
- Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neuronsInternational Journal of Neuropsychopharmacology, 2008
- Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicityNeuroscience, 2007